Using EGFR-driven NSCLC models, Sharma and colleagues showed that treatment with gefitinib or cisplatin results in a population of DTPs that have a repressed chromatin state induced by an upregulated IGF-1R signaling, whose inhibition is lethal to these cells [5]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.